# Treatment of Multiple Attacks of Acute Migraine (0462-025)

> **NCT00899379** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 473 (actual)

## Conditions studied

- Migraine Headache

## Interventions

- **DRUG:** rizatriptan benzoate
- **DRUG:** Comparator: Placebo

## Key facts

- **NCT ID:** NCT00899379
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-04
- **Primary completion:** 1996-01
- **Final completion:** 1996-04
- **Target enrollment:** 473 (ACTUAL)
- **Last updated:** 2022-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00899379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00899379, "Treatment of Multiple Attacks of Acute Migraine (0462-025)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00899379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*